GALECTIN THERAPEUTICS INC — Director's Dealing 2019

Jun 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2019-06-04

Reporting Person: Shlevin Harold H. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-04	Common Stock	M	8706	$1.37	Acquired	8706	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-04	Stock option (right to buy)	$1.37	M	8706	Disposed	2026-01-20	Common Stock (8706)	Direct

Footnotes

F1: The options were originally issued on January 20, 2016 in a grant of 38,000 options which vested 25% upon grant and then approximately 792 options vested per month through January 2019.